Abstract:<h3 class="Heading">Background</h3><p class="Para">Economic evaluation can inform whether strategies designed to improve the quality of health care delivery and the uptake of evidence-based practices represent a cost-effective use of limited resources. We report a systematic review and critical appraisal of the application of health economic methods in improvement/implementation research.</p><h3 class="Heading">Method</h3><p class="Para">A systematic literature search identified 1668 papers across the Agris, Embase, Global Health, HMIC, PsycINFO, Social Policy and Practice, MEDLINE and EconLit databases between 2004 and 2016. s were screened in Rayyan database, and key data extracted into Microsoft Excel. Evidence was critically appraised using the Quality of Health Economic Studies (QHES) framework.</p><h3 class="Heading">Results</h3><p class="Para">Thirty studies were included—all health economic studies that included implementation or improvement as a part of the evaluation. Studies were conducted mostly in Europe (62%) or North America (23%) and were largely hospital-based (70%). The field was split between improvement (<em class="EmphasisTypeItalic">N</em> = 16) and implementation (<em class="EmphasisTypeItalic">N</em> = 14) studies. The most common intervention evaluated (43%) was staffing reconfiguration, specifically changing from physician-led to nurse-led care delivery. Most studies (<em class="EmphasisTypeItalic">N</em> = 19) were ex-post economic evaluations carried out empirically—of those, 17 were cost effectiveness analyses. We found four cost utility analyses that used economic modelling rather than empirical methods. Two cost-consequence analyses were also found. Specific implementation costs considered included costs associated with staff training in new care delivery pathways, the impacts of new processes on patient and carer costs and the costs of developing new care processes/pathways. Over half (55%) of the included studies were rated 'good' on QHES. Study quality was boosted through inclusion of appropriate comparators and reporting of incremental analysis (where relevant); and diminished through use of post-hoc subgroup analysis, limited reporting of the handling of uncertainty and justification for choice of discount rates.</p><h3 class="Heading">Conclusions</h3><p class="Para">The quantity of published economic evaluations applied to the field of improvement and implementation research remains modest; however, quality is overall good. Implementation and improvement scientists should work closely with health economists to consider costs associated with improvement interventions and their associated implementation strategies. We offer a set of concrete recommendations to facilitate this endeavour.</p>

Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model.

Incorporating healthcare access and equity in economic evaluations: a scoping review of guidelines

Equity in national healthcare economic evaluation guidelines: Essential or extraneous?

A sporadic case of central core disease.

An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations

Use of health economic evaluation in the implementation and improvement science fields—a systematic literature review

Title : Voice Processing Abilities in Children with Autism Children with Specific Language Impairments and Young Typically Developing Children

Assessment of the quality of pharmacoeconomic evaluation literature in China

Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice.

What methods are currently available for incorporating implementation considerations within the economic evaluation of health technologies? A scoping review

PD12 Quality Assessment of Health Economic Evaluation on Screening Programs from China

Evaluation and Characterization of Health Economics and Outcomes Research in SAARC Nations

A commentary on "Guideline for economic evaluation of healthcare technologies in Japan"

Economic evaluations of artificial intelligence-based healthcare interventions: A systematic literature review of best practices in their conduct and reporting

Health Technology Assessment and Its Use in Drug Policies in China

Guidelines for Pharmacoeconomic Studies

Algorithms and heuristics of health technology assessments: A retrospective analysis of factors associated with HTA outcomes for new drugs across seven OECD countries

Use of economic evaluation in local health care decision-making in England: a qualitative investigation

Influencing Factors of Health Technology Assessment to Orphan Drugs: Empirical Evidence in England, Scotland, Canada, and Australia

OP27 Health Technology Assessment Processes, Characteristics, And Key Differences In High, Middle, And Low-Income Countries Of Asia Pacific Region

The Comparative Effects of Hard and Soft Ionizing Radiations on Male and Female Ring X Drosophila in Air and Nitrogen.